This is a very interesting and important question.
In the end of year update it was reported that there were 135 centres re-ordering the product and recently Morgan's announced there were "well over 150." Makes sense. So say we're adding 20-25 centres a month currently, I'm going to take that up to 30 a month over the remaining 11 months of the year as our exposure continues to grow and grow and we enter new markets (MENA announced first sales today) so that would be 155 + 330 = 485
That's not all.
Vascular centres are currently coming on board and I predict we could pick up anywhere between 50-100 over the course of this year which would give us between 535 - 585 centres by the end of this year for cardiac and vascular combined.
I previously predicted 400 although am now going with 550 centres by years end.*
*Is it any surprise management are dramatically scaling up manufacturing of CardioCel!?
- Forums
- ASX - By Stock
- AVR
- Centres by end of year?
Centres by end of year?, page-8
-
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.14 |
Change
0.140(1.08%) |
Mkt cap ! $277.7M |
Open | High | Low | Value | Volume |
$13.20 | $13.50 | $13.14 | $559.5K | 42.05K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1180 | $13.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.35 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 680 | 13.000 |
1 | 1000 | 12.950 |
2 | 67 | 12.900 |
1 | 1000 | 12.800 |
1 | 37 | 12.000 |
Price($) | Vol. | No. |
---|---|---|
13.350 | 500 | 1 |
13.500 | 2000 | 1 |
13.510 | 46 | 1 |
13.900 | 300 | 1 |
14.440 | 25 | 1 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
NEWS
Biotech innovator secures $5.5M R&D tax incentive refund – major boost for cutting-edge programs
NEWS
Exceptional lithium assays uncovered at Falcon Lake – expanding mineralisation, big potential ahead
AVR (ASX) Chart |